With 3.81 million shares changed hands, the volume of the stock remained heavier than its average volume of 67600.0 shares. During the session, the Health Information Services company that operates in wider Healthcare sector, reached to the highest price of $12.03 whereas the lowest price it dropped to was $9.46. The 52-week range on ACON shows that it touched its highest point at $3499.51 and its lowest point at $6.20 during that stretch. It currently has a 1-year price target of $22.00. Beta for the stock currently stands at 1.27.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ACON was up-trending over the past week, with a rise of 26.67%, but this was up by 25.52% over a month. Three-month performance surged to 32.11% while six-month performance rose 16.33%. The stock lost -99.26% in the past year, while it has lost -99.39% so far this year. A look at the trailing 12-month EPS for ACON yields -2920.94 with Next year EPS estimates of -13.33. For the next quarter, that number is -2.64. This implies an EPS growth rate of 99.80% for this year and 11.60% for next year.
Float and Shares Shorts:
At present, 0.58 million ACON shares are outstanding with a float of 0.58 million shares on hand for trading. On 2025-09-30, short shares totaled 12639.0, which was 217.0 higher than short shares on 1756425600. In addition to Dr. Jeffrey John Thramann M.D. as the firm’s Executive Chairman, Mr. Brent Ness serves as its CEO, President & Director.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-06-30, ACON reported revenue of $19319.0 and operating income of -$1736508.0. The EBITDA in the recently reported quarter was -$1548240.0 and diluted EPS was -$2.75.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential. With ACON analysts setting a high price target of 22.0 and a low target of 22.0, the average target price over the next 12 months is 22.0. Based on these targets, ACON could surge 127.04% to reach the target high and rise by 127.04% to reach the target low. Reaching the average price target will result in a growth of 127.04% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$7371.675 being high and -$7371.675 being low. For ACON, this leads to a yearly average estimate of -$7371.675. The surprise factor in the prior quarter was -$1447.19. Based on analyst estimates, the high estimate for the next quarter is -$3.84 and the low estimate is -$3.84. The average estimate for the next quarter is thus -$3.84.
